XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive (Loss)
Balance, beginning of period (in shares) at Dec. 31, 2021   81,712      
Balance, beginning of period at Dec. 31, 2021 $ 416,088 $ 817 $ 145,810 $ 276,449 $ (6,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares)   (242)      
Repurchase of common stock (22,583) $ (2) (22,581)    
Issuance of common stock for stock compensation plans (in shares)   297      
Issuance of common stock for stock compensation plans (12,128) $ 3 (12,131)    
Issuance of common stock under the employee stock purchase plan (in shares)   35      
Issuance of common stock under the employee stock purchase plan 2,446   2,446    
Stock-based compensation 28,227   28,227    
Cash dividends declared ($0.03 per share) (2,455)     (2,455)  
Other comprehensive (loss) income (2,548)       (2,548)
Net (loss) (379)     (379)  
Balance, end of period (in shares) at Mar. 31, 2022   81,802      
Balance, end of period at Mar. 31, 2022 406,668 $ 818 141,771 273,615 (9,536)
Balance, beginning of period (in shares) at Dec. 31, 2021   81,712      
Balance, beginning of period at Dec. 31, 2021 416,088 $ 817 145,810 276,449 (6,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive (loss) income (15,163)        
Net (loss) (286,675)        
Balance, end of period (in shares) at Jun. 30, 2022   81,940      
Balance, end of period at Jun. 30, 2022 133,779 $ 819 170,251 (15,140) (22,151)
Balance, beginning of period (in shares) at Mar. 31, 2022   81,802      
Balance, beginning of period at Mar. 31, 2022 406,668 $ 818 141,771 273,615 (9,536)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares)   (38)      
Repurchase of common stock (1,925)   (1,925)    
Issuance of common stock for stock compensation plans (in shares)   117      
Issuance of common stock for stock compensation plans (3,251) $ 1 (3,252)    
Issuance of common stock under the employee stock purchase plan (in shares)   59      
Issuance of common stock under the employee stock purchase plan 2,357   2,357    
Stock-based compensation 31,300   31,300    
Cash dividends declared ($0.03 per share) (2,459)     (2,459)  
Other comprehensive (loss) income (12,615)       (12,615)
Net (loss) (286,296)     (286,296)  
Balance, end of period (in shares) at Jun. 30, 2022   81,940      
Balance, end of period at Jun. 30, 2022 $ 133,779 $ 819 170,251 (15,140) (22,151)
Balance, beginning of period (in shares) at Dec. 31, 2022 82,436 82,436      
Balance, beginning of period at Dec. 31, 2022 $ 130,843 $ 824 229,602 (76,513) (23,070)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for stock compensation plans (in shares)   452      
Issuance of common stock for stock compensation plans 672 $ 4 668    
Issuance of common stock under the employee stock purchase plan (in shares)   52      
Issuance of common stock under the employee stock purchase plan 2,143 $ 1 2,142    
Stock-based compensation 42,557   42,557    
Cash dividends declared ($0.03 per share) (2,488)   (2,488)    
Other comprehensive (loss) income 1,543       1,543
Net (loss) (20,774)     (20,774)  
Balance, end of period (in shares) at Mar. 31, 2023   82,940      
Balance, end of period at Mar. 31, 2023 $ 154,496 $ 829 272,481 (97,287) (21,527)
Balance, beginning of period (in shares) at Dec. 31, 2022 82,436 82,436      
Balance, beginning of period at Dec. 31, 2022 $ 130,843 $ 824 229,602 (76,513) (23,070)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive (loss) income 1,709        
Net (loss) $ (67,578)        
Balance, end of period (in shares) at Jun. 30, 2023 83,212 83,212      
Balance, end of period at Jun. 30, 2023 $ 145,396 $ 832 310,016 (144,091) (21,361)
Balance, beginning of period (in shares) at Mar. 31, 2023   82,940      
Balance, beginning of period at Mar. 31, 2023 154,496 $ 829 272,481 (97,287) (21,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for stock compensation plans (in shares)   225      
Issuance of common stock for stock compensation plans 1,826 $ 2 1,824    
Issuance of common stock under the employee stock purchase plan (in shares)   47      
Issuance of common stock under the employee stock purchase plan 1,981 $ 1 1,980    
Stock-based compensation 36,227   36,227    
Cash dividends declared ($0.03 per share) (2,496)   (2,496)    
Other comprehensive (loss) income 166       166
Net (loss) $ (46,804)     (46,804)  
Balance, end of period (in shares) at Jun. 30, 2023 83,212 83,212      
Balance, end of period at Jun. 30, 2023 $ 145,396 $ 832 $ 310,016 $ (144,091) $ (21,361)